Dr. Asghari, deputy minister, Dr. Borandegi, director of pharmaceutical products in the FDA and Dr. Sheibani Chairman of Iranian Pharma syndicate among other officials honored Actero with their presence and could witness firsthand the progress of the plant.

“It is a pleasure to welcome our guests in Actero for this progress review. In less than one month, the Solid Dosage Form manufacturing line will start production and oncology products like Capecitabine ACTe will be produced locally”

Dr. Ravindra Babu, Plant Head

Actero is a pharmaceutical company specialized in high-quality oncology products and has over 15 products under development or pending Ministry of Health approval.